Erbium-169 has been used with considerable success as an intra-articular injection to treat persistent synovitis of the joints of the hand (Menkes et al., 1974) . In a double-blind controlled trial (Menkes et al., 1977) It was used in doses of 2 mCi for wrists, 1 0 mCi for metacarpophalangeal joints (MCPs) and 0 -5 mCi for proximal interphalangeal joints (PIPs). The corresponding volumes injected were 1 -36, 0 o 68, and 0 -34 ml. These were the minimum volumes possible with the limited concentration on arrival of the material; a smaller volume would have been preferred. The usual dose of methyl prednisolone acetate (as Depomedrone) was 40 mg to wrists, 20 mg to MCPs, and 10 mg to PIP joints. The retention of erbium-169 in treated joints was measured in most patients (J. C. W. Crawley, personal communication).
Assessments were made by the independent assessor (SAM), who remained unaware of the choice of injections throughout. The first was immediately before injection, and was repeated 3, 6, 12, and often 24 months afterwards, a fresh proforma being used each time. Each assessment included an index of general disease activity and examination 341 The joints injected are shown in Table 1 . All injections were performed in the x-ray department under screening control, and a small amount of contrast material was routinely injected to check that the needle tip was in fact intra-articular. In 4 additional joints the injector was unable to enter the joint and the attempt was abandoned. All patients completed a 1-year review. Only 1 joint was not assessed at 1 year because of a surgical procedure to the wrist involving repair of ruptured tendons.
Results
There was marked improvement in approximately 25% of the joints treated (Table 2 ) irrespective of whether they had been treated with erbium-169 or steroid. The response appeared to be related to the individual patient rather than to the type of injection. The trend was for all joints in a patient either to improve or to show no improvement, and this was maintained from the 3-month assessment to 1 year after injection. No patient identified joints that had improved soon after injection and subsequently deteriorated or others which improved only after an interval.
These subjective findings were confirmed by assessment of synovitis of the treated joints. There was either a marked or complete reduction of syno- In no patient was any acceleration of disease noted, nor did any problems follow the injections. The volume injected occasionally exceeded the apparent capacity of the joint, in which case the time taken for injection was prolonged. Although only cutaneous anaesthesia was used, no patient had undue discomfort or requested that the procedure be postponed or abandoned.
Discussion
Our results differ markedly from those obtained in previously published open and controlled trials of intra-articular erbium-169, although the response to steroid was comparable. The rate of improvement of 25 % in this trial should be compared with 54 -6% in an open trial (Menkes et al., 1974) , 58% in a double-blind controlled trial (Menkes et al., 1977) , and 64% in another open trial (Ott et al., 1977) . A major practical difference is that those workers all consider the coincidental injection of corticosteroid to be valuable in preventing an acute irradiation flare. This would suggest that there is an active synergism between erbium-1 69 and corticosteroid in finger joints. In the knee, our results with yttrium-90 without corticosteroid are comparable to those of others using yttrium-90 with corticosteroid.
The general design of this trial was complicated, in that individual joints in a hand were selected for isotope or steroid rather than hands or patients. Rather more care was necessary in the assessment, especially in the first, but an intrapatient comparison is always better than an interpatient comparison. Menkes et al. (1977) achieved both, as that controlled trial included a majority of patients receiving either isotope or saline, with an intrapatient comparison of isotope and saline in 27 patients. As comparable results were obtained with both methods of selection, and as the latter method was comparable to ours, the design of our trial clearly cannot be a major factor in the differing success rates. 
